Ra Capital Management, L.P. Tg Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

$7.17 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $17.3 Million - $45.2 Million	-2,210,145 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $28.7 Million - $67 Million	-1,888,187 Reduced 46.07%	2,210,145 $42 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $16.5 Million - $30.6 Million	755,589 Added 22.6%	4,098,332 $136 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $42 Million - $63.3 Million	-1,293,403 Reduced 27.9%	3,342,743 $130 Million
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $168 Million - $220 Million	-4,049,325 Reduced 46.62%	4,636,146 $223 Million
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $3.55 Million - $7.71 Million	-140,378 Reduced 1.59%	8,685,471 $452 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $73.3 Million - $108 Million	-3,962,608 Reduced 30.99%	8,825,849 $236 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $21.4 Million - $52.4 Million	2,401,046 Added 23.11%	12,788,457 $249 Million
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $3.62 Million - $8.11 Million	507,088 Added 5.13%	10,387,411 $102 Million
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $15.3 Million - $33.6 Million	3,000,000 Added 43.6%	9,880,323 $110 Million
Q2 2019 Aug 14, 2019	SELL	$6.27 - $8.65 $8.26 Million - $11.4 Million	-1,318,014 Reduced 16.08%	6,880,323 $59.5 Million
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $20.2 Million - $54.9 Million	3,919,541 Added 91.6%	8,198,337 $45.9 Million
Q2 2018 Aug 14, 2018	BUY	$12.5 - $15.0 $22.6 Million - $27.1 Million	1,806,452 Added 73.07%	4,278,796 $56.3 Million
Q1 2018 May 15, 2018	BUY	$8.7 - $16.8 $21.5 Million - $41.5 Million	2,472,344 New	2,472,344 $35.1 Million
Q4 2017 Feb 14, 2018	SELL	$7.35 - $12.3 $5.15 Million - $8.61 Million	-700,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.0 - $12.7 $7 Million - $8.89 Million	700,000	700,000 $8.3 Million

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$496 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$367 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$293 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$116 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$103 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.69B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Account